Cargando…
A community cluster of influenza A(H3N2) virus infection with reduced susceptibility to baloxavir due to a PA E199G substitution in Japan, February to March 2023
A community cluster of influenza A(H3N2) caused by viruses with an E199G substitution in PA was detected in Nara, Japan, between February and March 2023. The three patients with these mutant viruses had not received antiviral treatment before specimen collection but patients in the same hospital had...
Autores principales: | Takashita, Emi, Fujisaki, Seiichiro, Morita, Hiroko, Nagata, Shiho, Miura, Hideka, Matsuura, Yuki, Yamamoto, Saya, Chiba, Shoko, Inoue, Yumiko, Minami, Iori, Yoshikawa, Sayaka, Yamazaki, Seiko, Kishida, Noriko, Nakamura, Kazuya, Shirakura, Masayuki, Watanabe, Shinji, Hasegawa, Hideki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540515/ https://www.ncbi.nlm.nih.gov/pubmed/37768560 http://dx.doi.org/10.2807/1560-7917.ES.2023.28.39.2300501 |
Ejemplares similares
-
Human-to-Human Transmission of Influenza A(H3N2) Virus with Reduced Susceptibility to Baloxavir, Japan, February 2019
por: Takashita, Emi, et al.
Publicado: (2019) -
Susceptibility of Influenza Viruses to the Novel Cap-Dependent Endonuclease Inhibitor Baloxavir Marboxil
por: Takashita, Emi, et al.
Publicado: (2018) -
Rapid detection of an I38T amino acid substitution in influenza polymerase acidic subunit associated with reduced susceptibility to baloxavir marboxil
por: Nakauchi, Mina, et al.
Publicado: (2020) -
Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018
por: Takashita, Emi, et al.
Publicado: (2019) -
Influenza A(H3N2) virus exhibiting reduced susceptibility to baloxavir due to a polymerase acidic subunit I38T substitution detected from a hospitalised child without prior baloxavir treatment, Japan, January 2019
por: Takashita, Emi, et al.
Publicado: (2019)